The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-Adamantan-1-yl-3-[5-(7-methoxy-1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl]-thiourea ID: ALA4469066
PubChem CID: 155533705
Max Phase: Preclinical
Molecular Formula: C30H42N4OS
Molecular Weight: 506.76
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2nc3c(c(NCCCCCNC(=S)NC45CC6CC(CC(C6)C4)C5)c2c1)CCCC3
Standard InChI: InChI=1S/C30H42N4OS/c1-35-23-9-10-27-25(16-23)28(24-7-3-4-8-26(24)33-27)31-11-5-2-6-12-32-29(36)34-30-17-20-13-21(18-30)15-22(14-20)19-30/h9-10,16,20-22H,2-8,11-15,17-19H2,1H3,(H,31,33)(H2,32,34,36)
Standard InChI Key: DANIUTWEXULISV-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 41 0 0 0 0 0 0 0 0999 V2000
20.4298 -2.3319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1409 -1.9192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6060 -1.9192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8755 -0.8007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6993 -2.7033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1644 -2.7033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8755 -2.2906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4298 -1.5890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1409 -1.1763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6060 -1.1763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4298 -3.1532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7179 -3.5659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7179 -4.3872 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0061 -3.1532 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.0061 -4.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0061 -5.6172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2943 -6.0299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2943 -6.8512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5824 -7.2598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5824 -8.0811 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8706 -8.4938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4529 -9.3102 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8740 -9.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1695 -9.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1719 -10.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8780 -10.9424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5873 -10.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5815 -9.7098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4533 -8.4880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1631 -8.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1660 -7.2672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4609 -6.8564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7511 -7.2604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7465 -8.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3020 -10.9328 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3076 -11.7541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 5 1 0
3 6 1 0
4 8 1 0
5 1 1 0
6 1 1 0
7 3 1 0
8 1 1 0
9 4 1 0
10 4 1 0
11 1 1 0
9 2 1 0
10 3 1 0
7 2 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 30 2 0
29 22 2 0
22 24 1 0
23 21 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 23 2 0
29 30 1 0
29 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
27 35 1 0
35 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 506.76Molecular Weight (Monoisotopic): 506.3079AlogP: 6.14#Rotatable Bonds: 9Polar Surface Area: 58.21Molecular Species: BASEHBA: 4HBD: 3#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 8.92CX LogP: 5.69CX LogD: 4.33Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.28Np Likeness Score: -0.89
References 1. Pérez-Areales FJ, Turcu AL, Barniol-Xicota M, Pont C, Pivetta D, Espargaró A, Bartolini M, De Simone A, Andrisano V, Pérez B, Sabate R, Sureda FX, Vázquez S, Muñoz-Torrero D.. (2019) A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors., 180 [PMID:31351393 ] [10.1016/j.ejmech.2019.07.051 ]